Narrow search
Showing 1 - 8 of 8
Cover Image
Choosing among competing blockbusters: Does the identity of the third-party payer matter for prescribing doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - 2010
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10010274801
Cover Image
Choosing among competing blockbusters: Does the identity of the third-party payer matter for prescribing doctors?
Dalen, Dag Morten; Storisio, Enrico; Strøm, Steinar - 2009
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10010275649
Cover Image
A probability approach to pharmaceutical demand and price setting: Does the identity of the third-party payer matters for prescribing doctors?
Dalen, Dag Morten; Locatelli, Marilena; Sorisio, Enrico; … - 2011
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10010278848
Cover Image
An equilibrium model estimated on pharmaceutical data
Dalen, Dag Morten; Locatelli, Marilena; Strøm, Steinar - In: Atlantic economic journal : AEJ 46 (2018) 3, pp. 281-296
Persistent link: https://www.econbiz.de/10012062757
Cover Image
Choosing among Competing Blockbusters: Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - CESifo - 2010
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10008727300
Cover Image
Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten; Locatelli, Marilena; Sorisio, Enrico; … - In: Applied Economics and Finance 1 (2014) 1, pp. 39-54
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10010757740
Cover Image
Choosing among Competing Blockbusters: Does the Identity of the Third-party Payer Matter for Prescribing Doctors?
Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - Økonomisk institutt, Universitetet i Oslo - 2009
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper examines to what extent the identity of the...
Persistent link: https://www.econbiz.de/10004967612
Cover Image
A Probability Approach to Pharmaceutical Demand and Price Setting: Does the Identity of the Third-Party Payer Mattersfor Prescribing Doctors?
Dalen, Dag Morten; Locatelli, Marilena; Sorisio, Enrico; … - CESifo - 2011
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10009371358